Use of encapsulated dexamethasone sodium phosphate (eDSP) in chronic obstructive pulmonary disease, cystic fibrosis, and inflammatory bowel disorders.
Saved in:
| Title: | Use of encapsulated dexamethasone sodium phosphate (eDSP) in chronic obstructive pulmonary disease, cystic fibrosis, and inflammatory bowel disorders. |
|---|---|
| Authors: | Horn B; Quince Therapeutics, Inc., South San Francisco, CA, United States., Mambrini G; Quince Therapeutics, Inc., South San Francisco, CA, United States., Roden M; Quince Therapeutics, Inc., South San Francisco, CA, United States., Schaefer C; Quince Therapeutics, Inc., South San Francisco, CA, United States., Thye D; Quince Therapeutics, Inc., South San Francisco, CA, United States., Magnani M; Department of Biomolecular Sciences, University of Urbino, Urbino, Italy. |
| Source: | Frontiers in drug delivery [Front Drug Deliv] 2025 Dec 08; Vol. 5, pp. 1730142. Date of Electronic Publication: 2025 Dec 08 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918469589006676 Publication Model: eCollection Cited Medium: Internet ISSN: 2674-0850 (Electronic) Linking ISSN: 26740850 NLM ISO Abbreviation: Front Drug Deliv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
